Literature DB >> 22384865

Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy.

Roger Mazze1, Yariv Yogev, Oded Langer.   

Abstract

UNLABELLED: In pregnancy complicated by diabetes periods of hyperglycemia lead to accelerated fetal growth, resulting in a large for gestational age (LGA), or macrosomic, infant. Consequently, our aim was to measure the average volatility or variability in glucose control in women with and without diabetes in pregnancy.
METHODS: Continuous glucose monitoring (CGM) was employed in 82 pregnant study subjects to collect and record unbiased self-monitored glucose values. We obtained results from 51 women with normal glucose tolerance in pregnancy (NGTP), 25 gestational diabetes (GDM) and 6 women with pregestational diabetes (PreGD) between 18 and 45 (32 ± 6) years of age.
RESULTS: Significant differences (p < 0.001) were found in glucose exposure between NGT and all but PreGD; whereas the percent of time in hypoglycemia was significantly (p < 0.0001) higher in all pregnancy groups when compared to the nonpregnant sample. We conclude that CGM confirmed that diurnal glucose patterns differ throughout the day by 20% when pregnant and nonpregnant states are compared. Indeed, maintenance of a narrow range in pregnancy is characteristic in women without diabetes, and CGM throughout pregnancy is critical, if mimicking normal glucose patterns is to be achieved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22384865     DOI: 10.3109/14767058.2012.670413

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  16 in total

Review 1.  Role of continuous glucose monitoring in the management of diabetic pregnancy.

Authors:  Niranjala M Hewapathirana; Esther O'Sullivan; Helen R Murphy
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

2.  Glucose Profiles in Pregnant Women After a Gastric Bypass : Findings from Continuous Glucose Monitoring.

Authors:  Camille Bonis; Françoise Lorenzini; Monelle Bertrand; Olivier Parant; Pierre Gourdy; Charlotte Vaurs; Laurent Cazals; Patrick Ritz; Hélène Hanaire
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

Review 3.  Inpatient management of women with gestational and pregestational diabetes in pregnancy.

Authors:  Etoi A Garrison; Shubhada Jagasia
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

4.  Is It Safe to Use "On-Demand" Continuous Glucose Monitoring During Pregnancy?

Authors:  Sarit Polsky
Journal:  Diabetes Technol Ther       Date:  2018-03       Impact factor: 6.118

Review 5.  CGM, Pregnancy, and Remote Monitoring.

Authors:  Sarit Polsky; Rachel Garcetti
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

Review 6.  Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

Review 7.  Exercise in Pregnant Women with Diabetes.

Authors:  Tricia M Peters; Anne-Sophie Brazeau
Journal:  Curr Diab Rep       Date:  2019-08-06       Impact factor: 4.810

8.  Impact of Ramadan fasting on glucose levels in women with gestational diabetes mellitus treated with diet alone or diet plus metformin: a continuous glucose monitoring study.

Authors:  Bachar O Afandi; Mohamed M Hassanein; Lina M Majd; Nico J D Nagelkerke
Journal:  BMJ Open Diabetes Res Care       Date:  2017-12-04

Review 9.  Controversies and Advances in Gestational Diabetes-An Update in the Era of Continuous Glucose Monitoring.

Authors:  Marina P Carreiro; Anelise I Nogueira; Antonio Ribeiro-Oliveira
Journal:  J Clin Med       Date:  2018-01-25       Impact factor: 4.241

10.  Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

Authors:  Elizabeth R Seaquist; John Anderson; Belinda Childs; Philip Cryer; Samuel Dagogo-Jack; Lisa Fish; Simon R Heller; Henry Rodriguez; James Rosenzweig; Robert Vigersky
Journal:  Diabetes Care       Date:  2013-04-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.